High Risk Prostate Cancer

Also known as: High-risk Prostate Cancer

Drug	Drug Name	Drug Description
DB05812	Abiraterone	An antiandrogen used in the treatment of metastatic castration-resistant prostate cancer and metastatic high-risk castration-sensitive prostate cancer.

Drug	Drug Name	Target	Type
DB05812	Abiraterone	Steroid 17-alpha-hydroxylase/17,20 lyase	target
DB05812	Abiraterone	Serum albumin	carrier
DB05812	Abiraterone	Alpha-1-acid glycoprotein 1	carrier
DB05812	Abiraterone	Cytochrome P450 3A4	enzyme
DB05812	Abiraterone	Bile salt sulfotransferase	enzyme
DB05812	Abiraterone	Multidrug resistance-associated protein 1	transporter
DB05812	Abiraterone	Cytochrome P450 2D6	enzyme
DB05812	Abiraterone	Cytochrome P450 2C8	enzyme
DB05812	Abiraterone	Cytochrome P450 1A2	enzyme
DB05812	Abiraterone	Cytochrome P450 2C19	enzyme
DB05812	Abiraterone	Cytochrome P450 2C9	enzyme
DB05812	Abiraterone	Cytochrome P450 3A5	enzyme
DB05812	Abiraterone	Solute carrier organic anion transporter family member 1B1	transporter

Drug	Drug Name	Phase	Status	Count
DB05812	Abiraterone	2	Active Not Recruiting	1
DB05812	Abiraterone	2	Completed	1
DB05812	Abiraterone	2	Not Yet Recruiting	1
DB05812	Abiraterone	2	Recruiting	1
DB15074	Aglatimagene besadenovec	2	Recruiting	1
DB11901	Apalutamide	2	Recruiting	1
DB01128	Bicalutamide	2	Recruiting	1
DB11666	Buparlisib	2	Terminated	1
DB12218	Capivasertib	2	Not Yet Recruiting	1
DB08899	Enzalutamide	2	Completed	1
DB08899	Enzalutamide	2	Recruiting	1
DB15637	Fluzoparib	2	Active Not Recruiting	1
DB00007	Leuprolide	2	Completed	1
DB00007	Leuprolide	2	Recruiting	1
DB00281	Lidocaine	2	Completed	1
DB00860	Prednisolone	2	Recruiting	1
DB00635	Prednisone	2	Active Not Recruiting	1
DB00635	Prednisone	2	Completed	1
DB04485	Thymidine	2	Recruiting	1
DB00577	Valaciclovir	2	Recruiting	1